Medtronic plc

US$101.80As of Sun 8 Nov 2026, 12:00 UTC
NYSE:MDTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 4.96%
Div yield 2.83%
ROE 10.65%
Medical Devices
Beta (5Y) 0.57
PE TTM 25.08
TSR TTM 15.96%
Mkt cap US$124.6B
ROIC 8.59%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$131
29.09%
(2.11%)
Hold 5|0|11|11|3
2Q26
3Q26
4Q26
1Q27
Earnings per share$
1.55
1.50
1.65
1.59
32.97%
16.24%
19.59%
6.99%
Revenue$B
10.56
11.07
10.78
11.29
9.28%
15.79%
9.42%
11.08%
Peers (US$124.6B)
Cap (US$)
PE
15.34B
36.60x
7.713B
—
124.1B
34.70x
Capital
TTM
5Y
10Y
Leveragex
0.726
0.112
0.079
EBIT/Intx
1.385
0.066
0.074
Own earn%
(54.05)
(1.52)
(24.36)
Sh yield%
29.38
27.16
25.91
Owners
Insiders/Inst%
3.92
35.48
Short interest%
3.01
SBC / revenue%
5.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
16–26
$1 testx
—
Incr. ROIC%
3

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. Its Cardiovascular, Neuroscience, and Medical Surgical portfolios offer products including pacemakers, defibrillators, aortic valves, spinal cord stimulation systems, surgical stapling and robotic-assisted surgery products, and insulin pumps.